Abstract:Background: Fundc1 (FUN14 domain containing 1), an outer mitochondrial membrane protein, is important for mitophagy and mitochondria-associated endoplasmic reticulum membranes (MAMs). The roles of Fundc1 and MAMs in diabetic hearts remain unknown. The aims of this study, therefore, were to determine whether the diabetes mellitus–induced Fundc1 expression could increase MAM formation, and whether disruption of MAM formation improves diabetic cardiac function. Methods: Levels of FUNDC1 were examined in the hearts from diabetic patients and nondiabetic donors. Levels of Fundc1-induced MAMs and mitochondrial and heart function were examined in mouse neonatal cardiomyocytes exposed to high glucose (HG, 30 mmol/L D-glucose for 48 hours), and in streptozotocin-treated cardiac-specific Fundc1 knockout mice and cardiac-specific Fundc1 knockout diabetic Akita mice, as well. Results: FUNDC1 levels were significantly elevated in cardiac tissues from diabetic patients in comparison with those from nondiabetic donors. In cultured mouse neonatal cardiomyocytes, HG conditions increased levels of Fundc1, the inositol 1,4,5-trisphosphate type 2 receptor (Ip3r2), and MAMs. Genetic downregulation of either Fundc1 or Ip3r2 inhibited MAM formation, reduced endoplasmic reticulum-mitochondrial Ca2+ flux, and improved mitochondrial function in HG-treated cardiomyocytes. Consistently, adenoviral overexpression of Fundc1 promoted MAM formation, mitochondrial Ca2+ increase, and mitochondrial dysfunction in cardiomyocytes exposed to normal glucose (5.5 mmol/L D-glucose). In comparison with nondiabetic controls, levels of Fundc1, Ip3r2, and MAMs were significantly increased in hearts from streptozotocin-treated mice and Akita mice. Furthermore, in comparison with control hearts, diabetes mellitus markedly increased coimmunoprecipitation of Fundc1 and Ip3r2. The binding of Fundc1 to Ip3r2 inhibits Ip3r2 ubiquitination and proteasome-mediated degradation. Cardiomyocyte-specific Fundc1 deletion ablated diabetes mellitus–induced MAM formation, prevented mitochondrial Ca2+ increase, mitochondrial fragmentation, and apoptosis with improved mitochondrial functional capacity and cardiac function. In mouse neonatal cardiomyocytes, HG suppressed AMP-activated protein kinase activity. Furthermore, in cardiomyocytes of Prkaa2 knockout mice, expression of Fundc1, MAM formation, and mitochondrial Ca2+ levels were significantly increased. Finally, adenoviral overexpression of a constitutively active mutant AMP-activated protein kinase ablated HG-induced MAM formation and mitochondrial dysfunction. Conclusions: We conclude that diabetes mellitus suppresses AMP-activated protein kinase, initiating Fundc1-mediated MAM formation, mitochondrial dysfunction, and cardiomyopathy, suggesting that AMP-activated protein kinase–induced Fundc1 suppression is a valid target to treat diabetic cardiomyopathy.

Adiponectin Partially Rescues High Glucose/high Fat-Induced Impairment of Mitochondrial Biogenesis and Function in a PGC-1α Dependent Manner.

Impaired Mitochondrial Biogenesis Due to Dysfunctional Adiponectin-Ampk-pgc-1α Signaling Contributing to Increased Vulnerability in Diabetic Heart

Adiponectin exerts cardioprotective effects against high-glucose/high-fat-induced injury of neonatal rat cardiomyocytes through increasing mitochondrial biogenesis and function

Adiponectin Ameliorates Hyperglycemia-Induced Cardiac Hypertrophy and Dysfunction by Concomitantly Activating Nrf2 and Brg1

Reduced Cardioprotective Action of Adiponectin in High-Fat Diet-Induced Type II Diabetic Mice and Its Underlying Mechanisms.

Globular Domain Of Adiponectin Attenuates Post-Ischemia Myocardial Oxidative/Nitrative Stress In An Ampk-Independent Fashion

Adiponectin Deficiency Accentuates High Fat Diet‐Induced Cardiac Hypertrophy and Contractile Dysfunction Through Regulation of Autophagy

Hyperglycemia Altered the Fate of Cardiac Stem Cells to Adipogenesis Through Inhibiting the Β-Catenin/tcf-4 Pathway

Adiponectin Knockout Accentuates High Fat Diet-Induced Obesity and Cardiac Dysfunction: Role of Autophagy

Cardiac-derived Adiponectin Induced by Long-Term Insulin Treatment Ameliorates Myocardial Ischemia/reperfusion Injury in Type 1 Diabetic Mice Via AMPK Signaling

Adiponectin promotes repair of renal tubular epithelial cells by regulating mitochondrial biogenesis and function

Cardioprotective Effect of Adiponectin is Partially Mediated by Its AMPK-independent Antinitrative Action.

Dynamic Alteration Of Adiponectin/Adiponectin Receptor Expression And Its Impact On Myocardial Ischemia/Reperfusion In Type 1 Diabetic Mice

Globular Adiponectin Ameliorates Metabolic Insulin Resistance Via Ampk-Mediated Restoration of Microvascular Insulin Responses

PGC-1α Prevents Apoptosis in Adipose-Derived Stem Cells by Reducing Reactive Oxygen Species Production in a Diabetic Microenvironment.

Abstract 10526: Surface Located Adiponectin On Adipocytes-derived Exosomes Mediates Adipocytes/cardiomyocytes Communication And Contributes To Cardioprotection

Pgam5 aggravates hyperglycemia-induced myocardial dysfunction through disrupting Phb2-dependent mitochondrial dynamics

Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase &agr;2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo

Amp-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury But Has Minimal Effect On The Antioxidant/Antinitrative Protection Of Adiponectin

Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity

Adiponectin Attenuates Oxygen–Glucose Deprivation-Induced Mitochondrial Oxidative Injury and Apoptosis in Hippocampal HT22 Cells Via the JAK2/STAT3 Pathway